7446.T
The company operates in the Commodity Chemicals industry, producing and distributing chemical products, primarily generating revenue through the sale of these goods.
Business. The company operates in the Commodity Chemicals industry, producing and distributing chemical products, primarily generating revenue through the sale of these goods.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and distributing chemical products, primarily generating revenue through the sale of these goods.
The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.1, indicating a low reliance on debt financing. Its liquidity position is supported by a current ratio of 1.35 and cash and equivalents of 924,596,000 JPY, which provides a buffer against short-term obligations. The price-to-book ratio of 0.53 suggests the company is trading at a discount to its book value, potentially indicating undervaluation or asset-heavy operations.
Profitability metrics show a return on equity of 5.41% and a return on assets of 2.33%, both below the typical thresholds for high-performing chemical firms. The operating margin of 1.5% (calculated from operating income of 517,187,000 JPY on revenue of 34,442,625,000 JPY) is also below the industry median, suggesting the company may be facing cost pressures or pricing constraints.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution.
Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The current fiscal year's revenue of 34,442,625,000 JPY is expected to remain relatively flat, with a marginal change in operating income. The company's capital expenditure of -20,014,000 JPY indicates a reduction in investment, which may signal a focus on cost control rather than expansion.
Risk factors include low liquidity and dilution potential, though no immediate filing-based flags were detected. The company's low debt levels and strong cash position mitigate credit risk, but the low return on equity suggests operational inefficiencies or weak pricing power. The absence of dilution risk is a positive, but the company's conservative capital structure may limit growth opportunities.
Recent events include the latest financial filing, which disclosed the company's revenue and profitability figures. No significant corporate actions or regulatory changes were reported in the latest filings. The company's financial performance aligns with analyst estimates, with the last actual EPS of 475.93 JPY and revenue of 34,442,630,000 JPY.
- The company maintains a low debt-to-equity ratio of 0.1, indicating a conservative capital structure.
- The price-to-book ratio of 0.53 suggests the company is trading at a discount to its book value.
- The return on equity of 5.41% is below the industry median, indicating potential operational inefficiencies.
- The company's revenue is concentrated in a single business segment, increasing exposure to regional economic fluctuations.
- The company is projected to maintain a stable revenue trajectory with no significant growth or contraction expected.
- "margin_outlook_rationale": "The company's operating margin is expected to remain stable due to cost control measures and stable pricing.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 7446.T Market data — financials · 2026-05-27
- Tohoku Chemical Co Ltd Market data — analyst estimates · 2026-05-27